Medicine and Dentistry
Actinic Keratosis
10%
Adjuvant Therapy
6%
Biopsy
10%
Cancer
9%
Carcinogenesis
6%
Chemoprophylaxis
14%
Clinical Trial
15%
Confocal Microscopy
22%
Consumer
17%
Cryotherapy
10%
Cutaneous Melanoma
36%
Dermatological Agent
12%
Dermatology
28%
Dermatoscopy
17%
Diagnosis
11%
Disease
7%
Dysplastic Nevus Syndrome
21%
Gene Expression
10%
Gene Expression Profiling
11%
Health Care Cost
17%
Image Quality
9%
Immunotherapy
7%
Keratinocyte
9%
Malignant Neoplasm
12%
Melanocytic Nevus
5%
Melanoma Prevention
5%
Neoplasm
7%
Nevus Sebaceous
9%
Nodular Melanoma
100%
Non Melanoma Skin Cancer
10%
Photograph
9%
Pigmented Lesion
20%
Placebo
7%
Programmed Cell Death
9%
Protein P53
6%
Recurrent Disease
6%
Reflectance Confocal Microscopy
14%
Resatorvid
10%
Signal Transduction
7%
Skin Cancer
37%
Skin Cancer Prevention
6%
Skin Carcinogenesis
13%
Skin Carcinoma
8%
Skin Defect
26%
Skin Examination
7%
Squamous Cell Carcinoma
8%
Sun Exposure
5%
Teledermatology
17%
Thermoacoustic Imaging
5%
Toll Like Receptor 4
10%
Pharmacology, Toxicology and Pharmaceutical Science
Actinic Keratosis
11%
Adrenergic Receptor
5%
Basal Cell Carcinoma
5%
Carcinogenesis
6%
Caspase 7
5%
Cell Culture
11%
Cell Viability
5%
Clinical Trial
7%
Cohort Study
5%
Combination Therapy
11%
Confocal Microscopy
5%
Contact Allergy
5%
Cutaneous Melanoma
5%
Cytokeratin 17
5%
Diclofenac
5%
Dinucleotide
5%
Gellan
5%
Human
5%
Ichthyosis vulgaris
5%
Inositol Polyphosphate 5 Phosphatase
5%
Ipilimumab
10%
Leporidae
5%
Melanoma
33%
Methoxamine
5%
Monotherapy
9%
Mouse
19%
Murine
6%
Neoplasm
8%
Non Melanoma Skin Cancer
6%
Non-Steroidal Anti-Inflammatory Drug
7%
Perillyl Alcohol
5%
Phosphotransferase
8%
Photodynamic Therapy
5%
Placebo
7%
Protein Kinase Inhibitor
8%
Protein Kinases
13%
Protein P53
8%
Rapamycin
5%
Resatorvid
5%
Rocuronium
5%
Skin Cancer
32%
Skin Carcinogenesis
12%
Skin Carcinoma
9%
Squamous Cell Carcinoma
11%
Sulindac
5%
Talimogene Laherparepvec
10%
Thymidine
5%
Toll Like Receptor 4
5%
Ultraviolet Irradiation
8%
Vismodegib
5%
Keyphrases
Adjunct Screening
5%
Adjuvant Interferon
5%
Adolescent Patients
5%
Advanced Disease
5%
Advanced Melanoma
6%
Antigen Presentation
10%
Biological Response Modifiers
5%
Chemoprevention
5%
Chemotherapeutic Regimens
5%
Clinical Trials
6%
Clinically Significant
7%
Combination Therapy
10%
Confocal Microscope
10%
Early Cancer Detection
5%
Ex Vivo Human Skin
10%
High-risk of Recurrence
5%
Human Subjects
5%
Human Surface
5%
Immunotherapeutic Approaches
5%
Intralesional Bleomycin
5%
Ipilimumab
10%
Keratin 17
5%
Malignant Melanoma
8%
Melanoma
52%
Melanoma Detection
16%
Metastatic Melanoma
19%
Monoclonal Antibody
5%
Pediatric Patients
5%
Photographic Scale
5%
Protein Kinase Inhibitors
7%
Recurrence Risk
5%
Redox Signaling
5%
Retrospective Analysis
5%
Risk Threshold
5%
Sailing Races
5%
Salvage Therapy
5%
Skin Cancer
7%
Skin Carcinogenesis
16%
Solar Ultraviolet Radiation
16%
Speckle-free
5%
Sun Exposure Habits
5%
Surface Anatomy
5%
Survival Benefit
5%
T-LAK Cell-originated Protein Kinase
10%
Talimogene Laherparepvec (T-VEC)
10%
Topical Diclofenac
5%
Tumor
6%
Ultraviolet-induced
9%
United States
5%
Verruca Vulgaris
5%
